Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07215546

Enhanced Sternal Closure With Montage or Montage-CT to Evaluate Post-Operative Opioid Use Following Median Sternotomy

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Abyrx, Inc. · Industry
Sex
All
Age
19 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a retrospective study based on analysis real world data obtained from hospitals that have adopted use of Montage or Montage-CT for use following sternotomy. The analysis will report the post-operative use of analgesic medication (including opioids) and compare the use against a control group consisting of patients operated by the same surgeon concurrently or prior to adoption of Montage or Montage-CT for use in sternotomy closure.

Conditions

Interventions

TypeNameDescription
DEVICEMontage or Montage CTApplication of Montage or Montage-CT Settable Resorbable Bone Putty to the cut sternal edge at the time of closure.

Timeline

Start date
2025-10-01
Primary completion
2025-12-01
Completion
2026-04-01
First posted
2025-10-10
Last updated
2025-10-10

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07215546. Inclusion in this directory is not an endorsement.

Enhanced Sternal Closure With Montage or Montage-CT to Evaluate Post-Operative Opioid Use Following Median Sternotomy (NCT07215546) · Clinical Trials Directory